Skip to main content

FDA recall, , Moderate risk

Broadway Joe's Pain Cream

Broadway Joe's Pain Cream may be contaminated due to raw material issues.

What happened

Lexia LLC of Franklin, Tennessee is recalling Broadway Joe's Pain Cream products due to potential contamination of raw material used to manufacture the product. The recall, which began August 21, 2026, covers the 2 oz-jar and 4 oz-jar versions of the cream. The FDA added the recall to its Enforcement Report on September 1, 2026, and classified it on September 2, 2026. The products were distributed in Colorado.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

2 products

Match the lot code and NDC or UPC listed under your product.

A UPC is the number printed under a barcode. An NDC (National Drug Code) is usually printed on the drug's label.

  1. Broadway Joe's Pain Cream, (Histamine Dihydrochloride 0.025%)

    Strength
    1500 mg
    NDC or UPC
    • NDC 83088-8120-5
    • UPC 8 50041 64003 7
    Lot code
    • T1110
  2. Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate

    Strength
    3000 mg
    NDC or UPC
    • NDC 83088-8120-6
    • UPC 8 50041 64004 4
    Lot code
    • T1110

Recall details

Company began the recall
Company
Lexia LLCFranklin, Tennessee
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99751
Recall numbers
D-0828-2026 to D-0829-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report

  3. Classified by FDA · Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)